Mycoplasma Mastitis in Dairy Cattle Tim Brandes Iowa State University

Total Page:16

File Type:pdf, Size:1020Kb

Mycoplasma Mastitis in Dairy Cattle Tim Brandes Iowa State University Volume 61 | Issue 2 Article 4 1999 Mycoplasma Mastitis in Dairy Cattle Tim Brandes Iowa State University K. W. Kersting Iowa State University Follow this and additional works at: https://lib.dr.iastate.edu/iowastate_veterinarian Part of the Bacterial Infections and Mycoses Commons, Large or Food Animal and Equine Medicine Commons, and the Veterinary Pathology and Pathobiology Commons Recommended Citation Brandes, Tim and Kersting, K. W. (1999) "Mycoplasma Mastitis in Dairy Cattle," Iowa State University Veterinarian: Vol. 61 : Iss. 2 , Article 4. Available at: https://lib.dr.iastate.edu/iowastate_veterinarian/vol61/iss2/4 This Article is brought to you for free and open access by the Journals at Iowa State University Digital Repository. It has been accepted for inclusion in Iowa State University Veterinarian by an authorized editor of Iowa State University Digital Repository. For more information, please contact [email protected]. Mycoplasma Mastitis in Dairy Cattle TIM BRANDES, DVMt AND K.W. KERSTING, DVM, MStt Introduction a characteristic "fried egg" microcolony. These bacteria are considered Gram nega­ Mastitis is defined as inflammation of tive but stain better with Giemsa rather the mammary gland, usually due to mi­ than Gram stain.3 crobial infection. Many organisms have Over 100 Mycoplasma species have been known to cause mastitis including been identified to date, with more yet to bacteria, fungi, and yeast. Mastitis is the be named.2 Of the Mycoplasma species dis­ most economically important disease of covered, eight have been isolated from the the dairy industry, the condition has been bovine udder. By far the most frequent iso~­ estimated to cause as much as two billion late recovered is M. bovis, but others such dollars in lost income for United States as M canadense, M. bovigentalium, and M. dairy producers at a cost of $181 per cow californicum have also been cultured. 4 per year. 1 The biggest losses are due to Mycoplasma require special medium lowered production, but discarded milk, on which to grow. Beef infusion is the ba­ drugs, veterinary costs, and premature sic medium with 20% serum, yeast extract, culling also contribute to the losses. DNA, and other growth factors added. More than 130 different microorgan­ Along with the special medium, penicillin isms have been isolated from the mam­ and other antibiotics are added to aid in mary gland of the bovine with the major­ selection of Mycoplasma versus other bac­ ity of infections due to staphylococci, teria.3 Because these organisms lack a cell streptococci, and coliforms. However, my­ wall, beta-lactam antibiotics can be added coplasmas have begun to cause significant to the culture media and the growth of problems in some dairies. The first re­ mycoplasma is not affected. ported cases of mycoplasma mastitis were In vitro, mycoplasma species are sus­ in Europe in 1960. Since that time it has ceptible to antibiotics which act in other been found all around the world, includ­ ways besides inhibiting cell wall synthe­ ing the United States. Traditionally, Cali­ sis. However, the organism in vivo must fornia was most affected, but the disease function as a parasite in close contact with has now become a problem across the en­ host cells. Because of this close contact, tire country. 2 these microorganisms can obtain precur­ sor molecules from the host and thus be The Organism fairly resistant to the antibiotics that act by inhibiting bacterial protein synthesis.5 Mycoplasma are the smallest prokaryotic cells that can self-replicate. Their genomes Clinical Signs are simple and one-fifth the size of the av­ erage bacteria. These organisms do not As stated, the species most often impli­ have the genetic capability to produce a cated in mastitis is Mycoplasma bovis. cell wall, and are enclosed in a plasma This microorganism is a common inhabit­ membrane. Mycoplasmas can take many ant of the bovine upper respiratory tract, individual forms, including cocci, spirals, and is often involved in Bovine Respira­ filaments, and rings, but they all grow in tory Disease Complex and Enzootic Pneu­ monia of calves.6 Some other less common diseases 'Dr. Tim Brandes is a 1998 graduate of the Iowa State which have been linked to Mycoplasma University College of Veterinary Medicine. bovis are arthritis/synovitis, genital tract ttDr. K. W. Kersting is Associate Professor in the Depart­ 7 ment of Veterinary Diagnostic and Production Animal infections, abortion, and otitis media. Medicine at the ISU College of Veterinary Medicine. However, this discussion will be limited to 76 IOWA STATE UNIVERSITY VETERINARIAN mastitis. duce direct damage. Metabolic end prod­ Cows should be suspected of having a ucts and toxins can damage host cell mem­ Mycoplasma species infection if they have branes, and cause tissue damage.5 The severe purulent mastitis and no other sys­ host's own immune response causes tissue temic signs. Cows typically have mastitis destruction by a large inflammatory reac­ in more than one quarter, with a sharp tion of neutrophils, macrophages, plasma drop in milk production, sometimes ap­ cells, eosinophils, and fibroblasts. Initially proaching agalactia. Milk appearance can the alveoli and milk ducts fill with neu­ be tannish to brown with flaky sediment.6 trophils and the epithelium of the ducts However, milk appearance is not a sensi­ begin to divide, eventually filling the duct. tive indicator for early infection and re­ Meanwhile, alveolar epithelium undergoes searchers have discovered that 106 to 108 the opposite reaction: cells involute, milk colony forming units of Mycoplasma bovis production drops, and the cistern fills with per milliliter of milk can be shed for two exudate. Where the reaction is severe, the to three days preceding any changes in alveoli and ducts are replaced by fibrous milk appearance. The California Mastitis scar tissue and are permanently lost; the Test will be negative the first two to three areas less severely affected may begin pro­ days of infection but from three to seven ducing milk again but at a lower level. days post infection both CMT and milk ap­ Cows typically have numerous abscess in pearance will indicate mastitis. At some their mammory glands, ranging in size point during the initial week of infection from microscopic to ten centimeters in di­ the cow's milk production will drop dra­ ameter.5 Generally, the host's immune re­ matically and not rebound for months.2 sponse to Mycoplasma bovis is considered Despite the involvement of more than one reactive versus protective. The reactive quarter and severe inflammation the in­ response leads to necrosis of mammary fected cows rarely go offfeed or elicit a fe­ tissue and established foci of infection, ver.8 causing reduced milk secretion. In addi­ Mycoplasma bovis can occasionly in­ tion, the abscesses are known to harbor fect quarters where other pathogens al­ viable Mycoplasma bovis, which may be ready occur, allowing for variation in clini­ responsible for long-term intermittent cal signs depending on the other bacteria shedding by infected cOWS. 5,11 involved. Also on occasion cows can shed this organism and never show clinical Diagnosis signs, complicating control and outcome of an outbreak. It should be noted that be­ If cows are showing the clinical signs dis­ cause of a cow's ability to shed Myco­ cussed earlier, quarter and composite milk plasma bovis for variable amounts of time, samples from cows suspected of infection she should be considered positive for life.9 should be submitted for culture. Enriched media is used to isolate this organism, and Pathogenesis a special request is often required by the veterinarian in order for the laboratory to Along with the common mastitis bacteria conduct the culture for Mycoplasma sp. Staphylococcus aureus and Streptococcus Samples should be kept cold or may be fro­ agalactiae, Mycoplasma bovis is consid­ zen for up to two weeks before arrival at ered a contagious pathogen, thus infection the laboratory. The milk is then plated is spread during the milking procedure. directly on to the mycoplasma media and Because as few as 70 colony forming units incubated at 37°C in a five to ten percent per milliliter can cause infection, M. bovis C02 atmosphere. Usually growth can be can be spread easily from cow to cow with seen in two to three days, but some myco­ poor milking hygiene, contaminated equip­ plasma require up to six or seven days of ment, and via milkers' hands.10 incubation before growth is seen. Another Although the majority of tissue dam­ helpful diagnostic step is routine cultur­ age is due to the cow's own immune re­ ing of the bulk tank; this can help moni- sponse, mycoplasma themselves can pro- continued on page 80 VOL 61, No 2; FALL 1999 77 tor a herd for early infection. If culture is ten futile and not recommended.12 positive, individual cows can be cultured Experimental vaccines for prevention in order to identify individuals with mas­ of m:ycoplasma arthritis have given re­ titis. searchers hope in prevention of mastitis Culturing is the test of choice for con­ through vaccination. The few cows that are firming a suspected case. However, in or­ able to clear the infection on their own are der to identify the species of mycoplasma, less inclined to become reinfected. How­ different tests are required. ever, attempts at protection through Imunofluorescence and immunoblotting parenteral and intramammary immuniza­ on colonies transferred to a nitrocellulose tion have been disappointing. Both modi­ membrane are the common methods used fied live and killed Mycoplasma bovis vac­ to differentiate species. Because Myco­ cines have been used and neither was plasma bovis is considered the most patho­ proven to be effective. These experimen­ genic mycoplasma that causes mastitis, it tal trials have elicited a humoral response, is important to identify isolates down to but this has not been proven to be protec-­ the species in order to take the appropri­ tive against mastitis.13 ate control measures and reduce spread Many herd outbreaks of mycoplasma to naIve cows.
Recommended publications
  • National Program Assessment, Animal Health: 2000-2004
    University of Nebraska - Lincoln DigitalCommons@University of Nebraska - Lincoln U.S. Department of Agriculture: Agricultural Publications from USDA-ARS / UNL Faculty Research Service, Lincoln, Nebraska 10-5-2004 National Program Assessment, Animal Health: 2000-2004 Cyril G. Gay United States Department of Agriculture, Agricultural Research Service, National Program Staff, [email protected] Follow this and additional works at: https://digitalcommons.unl.edu/usdaarsfacpub Part of the Agriculture Commons, Animal Sciences Commons, and the Animal Studies Commons Gay, Cyril G., "National Program Assessment, Animal Health: 2000-2004" (2004). Publications from USDA- ARS / UNL Faculty. 1529. https://digitalcommons.unl.edu/usdaarsfacpub/1529 This Article is brought to you for free and open access by the U.S. Department of Agriculture: Agricultural Research Service, Lincoln, Nebraska at DigitalCommons@University of Nebraska - Lincoln. It has been accepted for inclusion in Publications from USDA-ARS / UNL Faculty by an authorized administrator of DigitalCommons@University of Nebraska - Lincoln. U.S. government work. Not subject to copyright. National Program Assessment Animal Health 2000-2004 National Program Assessments are conducted every five-years through the organization of one or more workshop. Workshops allow the Agricultural Research Service (ARS) to periodically update the vision and rationale of each National Program and assess the relevancy, effectiveness, and responsiveness of ARS research. The National Program Staff (NPS) at ARS organizes National Program Workshops to facilitate the review and simultaneously provide an opportunity for customers, stakeholders, and partners to assess the progress made through the National Program and provide input for future modifications to the National Program or the National Program’s research agenda.
    [Show full text]
  • Help Protect Your Herd with the Total Package. Demonstrated Safety and Efficacy
    ENVIRACORTM J-5 | MASTITIS PREVENTION HELP PROTECT YOUR HERD WITH THE TOTAL PACKAGE. DEMONSTRATED SAFETY AND EFFICACY. ENVIRACORTM J-5 | MASTITIS PREVENTION Coliform mastitis. Frightening in its severity and frequent fatality. Well-managed herds that have effectively controlled contagious mastitis are especially at risk for coliform mastitis. It carries the greatest potential for losing a quarter or even the cow, in part 60 to 70 because of bacterial endotoxins. percent70 to 80 Escherichia coli can be found throughout a cow’s environment. Coliformpercent mastitis infections • Up to 53 percent of all coliform mastitis cases are caused by that become clinical1 environmental bacteria.4 • E. coli is the primary bacterium responsible.5 • Milk should be cultured to learn which bacteria are involved so a vaccination program can be targeted. Vaccination should be part of every E. coli mastitis management 50 percent program. E. coli mastitis infections While complete prevention of E. coli mastitis is impossible, established during the dry period that remain dormant vaccination with an E. coli vaccine will help lessen the severity of until shortly after freshening2 cases and help provide an opportunity for successful treatment. $378.13 Average cost of each case of clinical E. coli mastitis3 When coliform mastitis occurs, it can cause: • Fever • Abnormal milk • Lack of appetite • Excessive udder edema • Diarrhea • Dehydration • Dramatic drop in milk production • Death A total package of safety and demonstrated efficacy. ENVIRACORTM J-5 is the safe and effective way to help control clinical signs associated with E. coli mastitis. Efficacy = 2 ½ days shorter duration of E. coli mastitis.6 The three-dose regimen helps stimulate the immune system for optimum response to help fight clinicalE.
    [Show full text]
  • PROGRAM and PROCEEDINGS Dr. Fredric W. Scott
    PROGRAM and PROCEEDINGS of the 94th Annual Meeting December 8, 9 and 10, 2013 Marriott, Downtown Magnificent Mile Chicago, Illinois Robert P. Ellis, Executive Editor http://www.cvmbs.colostate.edu/mip/crwad/ The 94th Annual Meeting of the CRWAD is dedicated to Dr. Fredric W. Scott Proceedings Distributed by CRWAD CRWAD 94th ANNUAL MEETING-2013 December 8 – 10, 2013 All attendees and presenters are required to wear their name badges at all times. Registration - 5th Floor Registration Booth Sunday 10 AM - 5:30 PM Monday 7:00 AM - Noon, 2 - 5 PM Tuesday 8 - 11 AM Researchers Reception - Welcome all attendees. Casual Wear Sunday, December 8, 6-8 PM – Grand Ballroom Salon III - 7th Floor Introduction of CRWAD Officers and Dedicatee, Poster Session I Student Reception – Students and invited guests - 5:00 PM – 5:45PM, Salon II Room, 7th Floor Business Meeting - Chicago Ballroom A/B/C/D 5th Floor 11:45 AM - 12:30 PM Tuesday, December 10 Dedication of the meeting, Introduction of New Members, Grad Student Awards New member applicants and students entered in competition are invited and encouraged to attend. Speaker Ready Room is: Streeterville Room (2nd floor) - Sunday, Dec. 8 - Monday, Dec. 9 Marriott Hotel Monday AM Monday PM Tuesday AM 8:00 - 11:30 1:30 - 4:30 8:00 - 11:30 Section Room Room Room Abstract Nos. Abstracts Nos. Abstracts Nos. Bacterial Avenue Ballroom Avenue Ballroom Pathogenesis 001 – 008 009 – 019 Biosafety and Denver/Houston Biosecurity 020 – 026 Companion Animal Epidemiology Michigan/Michigan Michigan/Michigan State State 027
    [Show full text]
  • Breeding for Disease Resistance in Farm Animals, 3Rd Edition
    BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION Bishop_FM.indd i 10/12/2010 3:05:45 PM Bishop_FM.indd ii 10/12/2010 3:05:45 PM BREEDING FOR DISEASE RESISTANCE IN FARM ANIMALS, 3RD EDITION Edited by Stephen C. Bishop The Roslin Institute and Royal (Dick) School of Veterinary Studies University of Edinburgh Midlothian, UK Roger F.E. Axford Formerly School of Agricultural and Forest Sciences University of Wales, Bangor UK Frank W. Nicholas Department of Animal Science University of Sydney Sydney, Australia and John B. Owen Formerly School of Agricultural and Forest Sciences University of Wales, Bangor UK Bishop_FM.indd iii 10/12/2010 3:05:45 PM CABI is a trading name of CAB International CABI Head Offi ce CABI North American Offi ce Nosworthy Way 875 Massachusetts Avenue Wallingford 7th Floor Oxfordshire OX10 8DE Cambridge, MA 02139 UK USA Tel: +44 (0)1491 832111 Tel: +1 617 395 4056 Fax: +44 (0)1491 833508 Fax: +1 617 354 6875 E-mail: [email protected] E-mail: [email protected] Website: www.cabi.org ©CAB International 2010. All rights reserved. No part of this publication may be reproduced in any form or by any means, electronically, mechanically, by photocopying, recording or otherwise, without the prior permission of the copyright owners. A catalogue record for this book is available from the British Library, London, UK. Library of Congress Cataloging-in-Publication Data Breeding for disease resistance in farm animals/edited by Stephen C. Bishop [et al.]. -- 3rd ed. p. cm. Includes bibliographical references and index.
    [Show full text]
  • Mastitis Therapy and Pharmacology of Drugs in the Bovine Mammary Gland
    Mastitis Therapy and Pharmacology of Drugs in the Bovine Mammary Gland (Q) n 0 K. L. Anderson, D. V.M., Ph.D. '"'O '-< Department of Food Animal and Equine Medicine ......'"i and Surgery (JQg School of Veterinary Medicine > North Carolina State University 8 (D 4700 Hillsborough Street ......'"i (") Raleigh, NC 27606 § >00 Introduction 00 0 (")...... control field Mastitis remains a major concern of the dairy industry, TABLE 1. Elimination of infections during mastitis a...... despite frequent use of therapy and application of mastitis experiments. (Natzke and Everett, 1975). 0 ~ control programs. Prevention and control are the most Infections eliminated via o/o 0 productive approaches to mastitis. However, therapy is 1-i; 18 to important for clinical mastitis and is a component of Spontaneous recovery 0 Lactational therapy 27 < mastitis control. Approximately 20-80% of cows are affect­ 5· Dry period therapy 34 (D ed by clinical mastitis annually (Dohoo, 1987, Wilesmith et Culling 14 ~ al., 1986). The annual US market for intramammary infu­ Not eliminated 7 ~ (") sion products is approximately $30 million (Gingerich, ,-+-...... 100 ,-+-...... 1987). Mastitis therapy should be efficacious, cost-effective, 0 ~ and antibiotic residues in meat and milk should be avoided. The application of mastitis control has influenced mastitis (D '"i The purpose of this paper is to discuss mastitis therapy and prevalence and etiology. Mastitis due to Str. agalactiae has 00 0 the pharmacology of drugs in the bovine mammary gland. been markedly reduced, with less dramatic reductions for '"'O (D Specific areas considered include: St. aureus. The most significant change has been the relative ~ 1.
    [Show full text]
  • 2017 National Veterinary Scholars Symposium 18Th Annual August 4
    2017 National Veterinary Scholars Symposium 18th Annual August – 4 5, 2017 Natcher Conference Center, Building 45 National Institutes of Health Bethesda, Maryland Center for Cancer Research National Cancer Institute with The Association of American Veterinary Medical Colleges https://www.cancer.gov/ Table of Contents 2017 National Veterinary Scholars Symposium Program Booklet Welcome .............................................................................................................................. 1 NIH Bethesda Campus Visitor Information and Maps .........................................................2 History of the National Institutes of Health ......................................................................... 4 Sponsors ............................................................................................................................... 5 Symposium Agenda .......................................................................................................6 Bios of Speakers ................................................................................................................. 12 Bios of Award Presenters and Recipients ........................................................................... 27 Training Opportunities at the NIH ...................................................................................... 34 Abstracts Listed Alphabetically .......................................................................................... 41 Symposium Participants by College of Veterinary Medicine
    [Show full text]
  • Susceptibility to Mastitis : a Review of Factors Related to the Cow B
    SUSCEPTIBILITY TO MASTITIS : A REVIEW OF FACTORS RELATED TO THE COW B. Poutrel To cite this version: B. Poutrel. SUSCEPTIBILITY TO MASTITIS : A REVIEW OF FACTORS RELATED TO THE COW. Annales de Recherches Vétérinaires, INRA Editions, 1982, 13 (1), pp.85-99. hal-00901361 HAL Id: hal-00901361 https://hal.archives-ouvertes.fr/hal-00901361 Submitted on 1 Jan 1982 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. SUSCEPTIBILITY TO MASTITIS : A REVIEW OF FACTORS RELATED TO THE COW B. POUTREL Institut National de la Recherche Agronomique, Station de Pathologie de la Reproduction, 37380 Nouzilly, France LA SENSIBILITÉ AUX MAMMITES : REVUE DES FACTEURS LIÉS A LA VACHE Facteurs de sensibilité ou de résistance Factors of susceptibility or resistance aux infections mammaires to mammary infections 1. Sensibilité aux infections liée à des caractéristiques 1. Physiological factors of the cow influencing suscepti- physiologiques de la vache bility to infection 1.1. Nombre et stade de lactation 1.1. Age and stage of lactation 1.2. Production, facilité et vitesse de traite 1.2. Milk yield, ease and milking rate 2. Sensibilité aux infections liée à des caractéristiques morphologiques de la mamelle et du trayon 2.
    [Show full text]
  • Dairy Cattle Mastitis in and Around Sebeta, Ethiopia
    Dairy Cattle Mastitis In and Around Sebeta, Ethiopia Hunderra Sori, DVM, MS1 Ademe Zerihun, DVM, MS, PhD2 Sintayehu Abdicho, DVM, MS3 1National Veterinary Institute Debrezeit, Ethiopia 2Faculty of Veterinary Medicine Debrezeit, Ethiopia 3National Animal Disease Research Center Sebeta, Ethiopia KEY WORDS: cattle, dairy, mastitis, ing number of functional quarters). The Sebeta, Ethiopia infection rate showed statistically significant difference between the lactating quarters ABSTRACT and non-lactating quarters (P < 0.01). The A total of 180 local and crossbred dairy infection rate also varied significantly (P < cows were examined to determine the over- 0.05) between crossbred (56.29%) and local all prevalence of mastitis in and around zebu (34.48%). The prevalence of mastitis Sebeta using Californian Mastitis Test also significantly differed between animals (CMT), which revealed the overall mastitis with teat lesion, teat end shape, and status of prevalence in the area as 52.78% (16.11% ventilation (P < 0.01), udder conformation clinical and 36.67% sub-clinical cases). Of (P < 0.05), type of management (P < 0.01), 134 bacterial isolates identified from CMT- and frequency of barn cleaning (P < 0.01). positive samples sent to a laboratory for In 53.13% of animals sampled and 31.68% microbiological examination, the majority of CMT-positive quarters, mixed infection of isolates were Staphylococcus aureus per animal and per quarter was observed. (44.03%) followed by Staphylococcus epi- d e r m i d i s (14.93%) and M i c r o c o c c u s s p e c i e s INTRODUCTION (6.72%), and lowest isolation rate was for Mastitis has been known to cause a great Escherichia coli and Pseudomonas aerugi- deal of loss or reduction of productivity, to nosa (0.75% each).
    [Show full text]
  • Mycoplasma Mastitis in Dairy Cows
    Mycoplasma Mastitis Can you Control it on Your Farm? Pamela Ruegg, DVM, MPVM Introduction Mastitis is a well-recognized and costly disease of dairy cattle. Most farmers are well acquainted with traditional causes of mastitis such as Staphylococcus aureus and Streptococcus agalactia. The widespread adoption of standard mastitis control practices such as teat dipping, dry cow therapy, appropriate treatment, judicious culling and good milking preparation has allowed many dairy farmers to control contagious forms of mastitis. In a recent study, Staph aureus and Strep ag accounted for only 8% of clinical mastitis cases in Ontario dairy herds.4 While these traditional forms of mastitis are now controllable, mastitis continues to require management attention Other organisms have emerged to fill the niche created by the control of contagious Fig 2: Mycoplasma Diagnosis in Wisconsin Fig 3: Mycoplasma Diagnosis in New York 60 60 50 50 40 40 30 30 20 20 Number of Herds Number of Herds 10 10 0 0 1992 1993 1994 1995 1996 1997 1998 1989 1990 1991 1992 1993 1994 organisms. An organism that is increasingly isolated from clinical mastitis in Wisconsin is Mycoplasma bovis (Fig 2). Prior to 1992, there were only 2 confirmed herd outbreaks within Wisconsin, between 1992 and 1998 at least 140 herd outbreaks of that organism were reported.5 A similar trend has been reported from dairies in New York (Fig 3).2 Mycoplasma mastitis was once considered to be a disease of large western dairy herds. In recent years it has become recognized in Midwest and Northeastern dairy regions. This presentation will review basic facts about mastitis caused by mycoplasma and discuss control strategies to minimize the risk of an outbreak.
    [Show full text]
  • Factors Associated with Intramammary Infection in Dairy Cows Caused By
    J. Dairy Sci. 100:493–503 https://doi.org/10.3168/jds.2016-11465 © 2017, THE AUTHORS. Published by FASS and Elsevier Inc. on behalf of the American Dairy Science Association®. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/). Factors associated with intramammary infection in dairy cows caused by coagulase-negative staphylococci, Staphylococcus aureus, Streptococcus uberis, Streptococcus dysgalactiae, Corynebacterium bovis, or Escherichia coli S. Taponen,*1 E. Liski,† A.-M. Heikkilä,† and S. Pyörälä* *Department of Production Animal Medicine, Faculty of Veterinary Medicine, University of Helsinki, Paroninkula 20, FI-04920 Saarentaus, Finland †Natural Resources Institute Finland, Viikinkaari 4, FI-00790 Helsinki, Finland ABSTRACT barns with parlor milking had an increased probability of contracting an IMI compared with cows in tiestall The aim of this study was to determine risk factors barns or in new freestall barns with automatic milking. for bovine intramammary infection (IMI) associated This was the case for all IMI, except those caused by with the most common bacterial species in Finland. CNS, the prevalence of which was not associated with Large databases of the Finnish milk-recording system the milking system, and IMI caused by Staph. aureus, and results of microbiological analyses of mastitic which was most common in cows housed in tiestall milk samples from Valio Ltd. (Helsinki, Finland) were barns. A better breeding index for milk somatic cell analyzed. The study group comprised 29,969 cows with count was associated with decreased occurrence of IMI, IMI from 4,173 dairy herds.
    [Show full text]
  • Enhancing Drug Efficacy Against Mastitis Pathogens—An in Vitro
    animals Article Enhancing Drug Efficacy against Mastitis Pathogens—An In Vitro Pilot Study in Staphylococcus aureus and Staphylococcus epidermidis Karthic Rajamanickam 1 , Jian Yang 1, Saravana Babu Chidambaram 2 and Meena Kishore Sakharkar 1,* 1 College of Pharmacy and Nutrition, University of Saskatchewan, 107 Wiggins Road, Saskatoon, SK S7N 5E5, Canada; [email protected] (K.R.); [email protected] (J.Y.) 2 Department of Pharmacology, JSS College of Pharmacy, JSS Academy of Higher Education & Research (JSS AHER), Mysuru-570015, Karnataka, India; [email protected] * Correspondence: [email protected] Received: 5 October 2020; Accepted: 9 November 2020; Published: 15 November 2020 Simple Summary: The success rate of antibiotic treatment of mastitis is highly variable. Concurrently, the efficacy of available antibiotics is compromised by the rapid emergence of drug-resistant bacteria. Recently, it was reported that there has been a reduction in the presence of antibiotic-resistant bacteria in food-producing animals where interventions provide for restrictions in antibiotic use. In addition, societal concerns regarding the use of antimicrobials in food animal production are putting increasing pressure on all aspects of livestock production. Here, we have conducted a systematic procedure for the identification of conserved and unique drug targets. We propose that combination therapy with drugs that work synergistically against conserved and unique targets can help increase efficacy and lower the usage of antibiotics for treating bacterial infections. An in vitro pilot validation of our findings in vitro for the two most common mastitis-causing bacteria in North America—Staphylococcus aureus and the coagulase-negative Staphylococcus epidermidis—is presented.
    [Show full text]
  • WELFARE ISSUES RELATED to MASTITIS in DAIRY COWS E
    Nº 10 / SEPTEMBER 2014 www.fawec.org THE farm ANIMAL welfare fact SHEET WELFARE ISSUES RELATED TO MASTITIS IN DAIRY COWS E. MAINAU, D. TEMPLE, X. MANTECA Mastitis is one of the major animal welfare and economic problems in dairy cattle production. Although in recent years there has been a general decline in the incidence of mastitis, high incidences such as 25-45% are still being currently reported. Mastitis is a multifactorial disease in which the environment, the pathogens and the host (cow) interact with each other. MASTITIS CAUSES PRODUCTION AND ECONOMIC LOSSES is a well-organised adaptive response of the animal to enhance di- sease resistance and recovery from disease. Pain caused by masti- Mastitis is one of the most costly diseases affecting dairy cattle. Di- tis may modify the expression of sickness behaviour. In particu- rect economic costs associated with mastitis include reduced milk lar, although lying time is usually increased during illness and it is yield and quality, increased veterinary costs, discarded milk (during thought to help the animal to save energy, cows with mastitis show the course of treatment) and somatic cell count (SCC) penalties. a reduction in lying time due to udder pain and this has important The main indirect costs, which are usually underestimated by far- negative effects on their welfare and production. It must not be mers, are the increased risk of culling and reduced fertility. On ave- underestimated that resting is a very important behaviour for dairy rage, each case of clinical mastitis causes an estimated loss of around cattle; healthy cows typically spend approximately 12-13 hours per 200 Euros.
    [Show full text]